Whitehawk Therapeutics (WHWK) Receivables - Net (2022 - 2024)
Historic Receivables - Net for Whitehawk Therapeutics (WHWK) over the last 3 years, with Q4 2024 value amounting to $5.9 million.
- Whitehawk Therapeutics' Receivables - Net rose 756.2% to $5.9 million in Q4 2024 from the same period last year, while for Dec 2024 it was $5.9 million, marking a year-over-year increase of 756.2%. This contributed to the annual value of $5.9 million for FY2024, which is 756.2% up from last year.
- As of Q4 2024, Whitehawk Therapeutics' Receivables - Net stood at $5.9 million, which was up 756.2% from $6.5 million recorded in Q3 2024.
- Whitehawk Therapeutics' 5-year Receivables - Net high stood at $6.5 million for Q3 2024, and its period low was $1.9 million during Q4 2022.
- Its 3-year average for Receivables - Net is $4.4 million, with a median of $5.2 million in 2023.
- Its Receivables - Net has fluctuated over the past 5 years, first soared by 19473.68% in 2023, then plummeted by 1135.67% in 2024.
- Over the past 3 years, Whitehawk Therapeutics' Receivables - Net (Quarter) stood at $1.9 million in 2022, then surged by 194.74% to $5.5 million in 2023, then grew by 7.56% to $5.9 million in 2024.
- Its Receivables - Net stands at $5.9 million for Q4 2024, versus $6.5 million for Q3 2024 and $5.9 million for Q2 2024.